wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33438428-95D46779-87D3-4368-A7A2-B4B44CF5C1CD
Q33438428-95D46779-87D3-4368-A7A2-B4B44CF5C1CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438428-95D46779-87D3-4368-A7A2-B4B44CF5C1CD
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
P2860
Q33438428-95D46779-87D3-4368-A7A2-B4B44CF5C1CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438428-95D46779-87D3-4368-A7A2-B4B44CF5C1CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8eb6066d6464bae8ee21fa562867ee0934dbf4ec
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies